GBA, You confuse the hell out of me, you are all over the board with so many different scenarios I no longer know where you are coming from, you have to know that a phase III is almost assured because of this: " Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide scientific rationale and clinical development perspectives for Brilacidin, the Company’s defensin mimetic drug candidate, as a potential novel coronavirus (COVID-19) treatment. Notably, Brilacidin is one of the few drugs targeting COVID-19 that has been tested in humans in Phase 2 clinical trials for other clinical indications, providing an established safety and efficacy profile, thereby potentially enabling it to rapidly help confront the emerging worldwide coronavirus crisis.
are you saying that all the recent, numerous studies are of no value in approving Brilacidin as a phase III candidate? What if they skip Phase II and advance to phase III based on the previous trials? Just asking.
Market Data 
Markets 
AI
